CML & PH+ All: There is so much more to know CML & PH+ All: There is so much more to know Explore
Think | Test | Treat

WHAT IS THINK
TEST TREAT?

The THINK TEST TREAT programme was initiated by Incyte to raise awareness of the importance of regular and sensitive BCR-ABL1 monitoring and guidance-compliant mutation testing in patients with Ph+ leukaemias

Read more

CML

Why is it important to think about sensitive BCR-ABL1 monitoring and mutation testing when treating patients with CML?

Read more

Ph+ ALL

Why is it important to monitor minimal residual disease and test for mutations when treating patients with Ph+ ALL?

Read more

NEW: CML Expert Videos

A series of short expert videos on topics highly relevant to CML treatment and diagnostics in 2022

VIEW VIDEOS

All AEs should be reported to the Global Medical Information Call Center by phone: +800 000 27423
(for local numbers see www.incyteglobalmedicalinformation.com/report-adverse-event.aspx).
Alternatively, you can report AEs by email: eumedinfo@incyte.com

For more information, please contact Incyte Medical Information: eumedinfo@incyte.com